Skip to main content

AlphaLISA High Performance Human IL-1β Detection Kit, 100 Assay Points

The AlphaLISA™ High Performance (HP) Human IL-1β Detection Kit is designed for the quantitative determination of human IL-1β in serum, buffered solution, or cell culture medium using a homogeneous (no wash steps, no separation steps) assay.

This kit is the new and improved version of part number AL220.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Feature Specification
Application Protein Quantification
Dynamic Range 0.37 - 30,000 pg/mL  
Limit of Detection 0.37 pg/mL  
Limit of Quantification 1.33 pg/mL  
Sample Volume 10 µL

The AlphaLISA™ High Performance (HP) Human IL-1β Detection Kit is designed for the quantitative determination of human IL-1β in serum, buffered solution, or cell culture medium using a homogeneous (no wash steps, no separation steps) assay.

This kit is the new and improved version of part number AL220.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Overview

Interleukin 1 beta (IL-1β) is a central player of the immune response, involved in inflammation at local and systemic levels. IL-1β is synthesized as a 31 kDa precursor that is cleaved by caspase-1 (ICE) into the active 17 kDa form and eventually released into extracellular space. Its production has been reported in many cell types including brain and monocytic and peripheral blood mononuclear cells. After binding to its receptor, IL-1RI, IL-1β triggers a cascade of kinase signaling pathways that lead to the activation of transcription factors like NFκB and AP-1, eventually activating the expression of genes such as MIP-2 and C-reactive protein.

Formats
  • Our 100 assay point kit allows you to run 100 wells in 96-well format, using a 100 µL reaction volume (10 µL of sample).
  • Our 500 assay point kit allows you to run 500 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).
  • Our 5,000 assay point kit allows you to run 5,000 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).
Features
  • No-wash steps, no separation steps
  • ELISA alternative technology
  • Sensitive detection
  • Broad sample compatibility
  • Small sample volume
  • Results in less than 3 hours
  • Half the time of an ELISA assay

AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.

Specifications

Application
Protein Quantification
Automation Compatible
Yes
Brand
AlphaLISA
Detection Modality
Alpha
Dynamic Range
0.37 - 30,000 pg/mL  
Limit of Detection
0.37 pg/mL  
Limit of Quantification
1.33 pg/mL  
Product Group
Kit
Sample Volume
10 µL
Shipping Conditions
Shipped in Blue Ice
Target
IL-1β
Target Class
Cytokines
Target Species
Human
Technology
Alpha
Therapeutic Area
Autoimmunity
Immuno-oncology
Inflammation
Metabolic
Neuroscience
Oncology
Unit Size
100 Assay Points

Video gallery

Resources

Are you looking for resources, click on the resource type to explore further.

1-6 of 8 Resources
Application Note Icon
Application Note
Best practices to measure cytokines in whole blood with AlphaLISA

Unlock the potential of whole blood analysis for a more accurate and physiologically relevant assessment of biomarkers. Whole...

Flyer Icon
Flyer
Cytokine AlphaLISA High performance kit flyer

Our R&D scientists were determined to enable your research by developing new and improved versions of our AlphaLISA cytokine...

Guide Icon
Guide
Download your guide about neurodegenerative diseases

Emerging pathways to neuroinflammation and neurodegeneration

Neurodegenerative diseases, such as amyotrophic lateral sclerosis...

Publication Icon
Literature - Publication Review
Fibrosis study investigating the role of the extracellular matrix in fibrosis disorder

Dive deeper into fibrosis research

In fibrotic disorders, the normal regulation of the extracellular matrix (ECM) is compromised...

Application Note Icon
Application Note
Homogeneous detection of cytokines from PBMC supernatants using AlphaLISA High Performance assays

Cytokines play an essential role in inflammatory processes, leading to their involvement in viral and bacterial infections, as...

Publication Icon
Literature - Publication Review
HTRF and AlphaLISA assays bring clarity to extracellular matrix related fibrosis development

Fibrotic disorders are complex diseases believed to stem from uncontrolled and excessive wound healing processes. The exact causes...

Scroll Icon